Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hair Loss”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05954104
What this trial is testing

Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma

Who this might be right for
Alopecia Areata
Egymedicalpedia 80
Testing effectiveness (Phase 2)Study completedNCT00484679
What this trial is testing

Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata

Who this might be right for
Alopecia Areata
University of Minnesota 18
Not applicableActive Not RecruitingNCT07228156
What this trial is testing

Study to Evaluate Xtresse Serum in Individuals With Thinning Hair

Who this might be right for
Thin HairHair LossAlopecia+1 more
Restore Biologics Holdings, Inc. dba Xtressé 40
Testing effectiveness (Phase 2)Looking for participantsNCT05866562
What this trial is testing

Dupilumab in the Treatment of Pediatric Alopecia Areata

Who this might be right for
Alopecia Areata
Icahn School of Medicine at Mount Sinai 76
Testing effectiveness (Phase 2)Study completedNCT01669746
What this trial is testing

Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 34
Testing effectiveness (Phase 2)Study completedNCT01900041
What this trial is testing

Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss

Who this might be right for
Female Pattern Hair LossAndrogenetic Alopecia (AGA)Ludwig Type 1+1 more
Merz Pharmaceuticals GmbH 74
Testing effectiveness (Phase 2)Study completedNCT01548066
What this trial is testing

The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss

Who this might be right for
Androgenetic AlopeciaMale Pattern Baldness
Seoul National University Hospital 40
Not applicableActive Not RecruitingNCT02530177
What this trial is testing

Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer

Who this might be right for
Non-Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center 546
Not applicableNot Yet RecruitingNCT07817277
What this trial is testing

Hair Changes in Females With Type 2 Diabetes Clinical and Trichoscopic Examination

Who this might be right for
Diabete MellitusFemale Androgenetic AlopeciaDermoscopy
Al-Azhar University 130
Not applicableUnknownNCT06218394
What this trial is testing

Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Second Affiliated Hospital, Zhejiang University, School of Medicine 135
Not applicableUnknownNCT06066827
What this trial is testing

Hair Regeneration in Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Dr. dr. Lili Legiawati, SpKK(K) 60
Very early researchActive Not RecruitingNCT07029204
What this trial is testing

Intralesional Cyclosporine for Alopecia Areata

Who this might be right for
Alopecia Areata
University of California, Davis 2
Not applicableUnknownNCT00197379
What this trial is testing

The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

Who this might be right for
Alopecia
Hamamatsu University 20
Early research (Phase 1)Active Not RecruitingNCT06799520
What this trial is testing

Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableUnknownNCT05588310
What this trial is testing

Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors

Who this might be right for
Alopecia Areata
University Hospital, Toulouse 150
Not applicableUnknownNCT05084417
What this trial is testing

A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions

Who this might be right for
Atopic DermatitisDermatologyVitiligo+3 more
OM1, Inc. 10,000
Post-approval studies (Phase 4)UnknownNCT04412148
What this trial is testing

Modified SALT Score for Alopecia Areata

Who this might be right for
Alopecia Areata
Kasr El Aini Hospital 20
Testing effectiveness (Phase 2)UnknownNCT00418249
What this trial is testing

Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women

Who this might be right for
Alopecia
Rabin Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT02528552
What this trial is testing

Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO

Who this might be right for
Androgenetic Alopecia
Theradome, Inc. 80
Not applicableLooking for participantsNCT05177289
What this trial is testing

Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia

Who this might be right for
Chemotherapy-induced Alopecia
Jessa Hospital 72
Next Page